Episodes

22.2 Steven Hayes, PhD: RFT, ACT, Evolution, The FLIP, and Mental Health
December 03, 2024x
2
01:01:2256.18 MB

22.2 Steven Hayes, PhD: RFT, ACT, Evolution, The FLIP, and Mental Health

Please join us this week for a discussion on Relational Frame Theory (RFT) and how it relates to Acceptance and Commitment Therapy/Training (ACT), with the conceptual creator of RFT and ACT, Dr. Steven Hayes. I highly recommend you view this on YouTube so you don't miss out on all the added video g...

22.1 Steven Hayes, PhD: ACT and Relational Frame Theory
November 26, 2024x
1
42:4339.1 MB

22.1 Steven Hayes, PhD: ACT and Relational Frame Theory

Please join us this week for a discussion on Relational Frame Theory (RFT) and how it relates to Acceptance and Commitment Therapy/Training (ACT), with the conceptual creator of RFT and ACT, Dr. Steven Hayes. I highly recommend you view this on YouTube so you don't miss out on all the added video g...

21.2 Dr. Robert Post, MD: Lithium, Dementia, and NIH Research Failures
November 19, 2024x
2
56:4451.93 MB

21.2 Dr. Robert Post, MD: Lithium, Dementia, and NIH Research Failures

This week, we're back to give you more information on bipolar illness, lithium, dementia, and the failures of the NIH in their research efforts, with one of the world's leading psychiatric experts, former Chief of the biological psychiatry branch of the National Institutes of Mental Health (NIMH) f...

21.1 Dr. Robert Post, MD: Youth-Onset Bipolar Illness
November 12, 2024x
1
56:4451.93 MB

21.1 Dr. Robert Post, MD: Youth-Onset Bipolar Illness

This week, we're back to give you more information on bipolar illness in youths and the use of lithium with one of the world's leading experts on both, former Chief of the biological psychiatry branch of the National Institutes of Mental Health (NIMH) for 20 years, Dr. Robert Post, MD and psychiatr...

20.1 Lithium: Beyond its' Psychiatric Use with Janusz Rybakowski, MD
November 05, 2024x
1
01:00:4855.65 MB

20.1 Lithium: Beyond its' Psychiatric Use with Janusz Rybakowski, MD

Hey there again... This week, we're back to give you more information on lithium with one of the world's leading experts on lithium, Dr. Janusz Rybakowski, MD and Polish psychiatrist. Janusz was one of the first researchers in the world to illuminate some of the ancillary medical benefits of lithiu...

19.1 The Problem with Rapid Benzo Detox; Patient Perspective with Nicole Lamberson, PA
October 30, 2024x
1
01:14:5268.54 MB

19.1 The Problem with Rapid Benzo Detox; Patient Perspective with Nicole Lamberson, PA

Hey all, hope you enjoy this latest episode with Nicole Lamberson, PA with the Taper Clinic, who graciously has shared her story about being over-medicated on psychiatric medications. We discuss why limited duration 'Rehab' and 'Detox' units can be extremely harmful to patients with dependence on c...

18.2 How We Should Be Practicing Psychiatry with Cara Hoepner, PMHNP
October 22, 2024x
2
42:4739.16 MB

18.2 How We Should Be Practicing Psychiatry with Cara Hoepner, PMHNP

Join me with Cara Hoepner, a San Francisco-based PMHNP, to discuss how we SHOULD be practicing psychiatry. This is a 2-part series and in this 2nd part, we talk more about some of the issues that plague our field. We talk about how our first imperative has to be to rule out any medical cause of psy...

18.1 How We Should Be Practicing Psychiatry with Cara Hoepner, PMHNP
October 15, 2024x
1
59:0454.06 MB

18.1 How We Should Be Practicing Psychiatry with Cara Hoepner, PMHNP

Join me with Cara Hoepner, a San Francisco-based PMHNP, to discuss how we SHOULD be practicing psychiatry. This is a 2-part series and in this first part, we will talk more about Cara's background that led her into psychiatric practice, then discuss the inherent problems with the DSM's massive over...

17.1 Clozapine Underutilization with Jose Rubio, MD
October 01, 202401:11:0165.01 MB

17.1 Clozapine Underutilization with Jose Rubio, MD

Clozapine is one of the first antipsychotics with a unique chemical structure compared to any other antipsychotic. It is the most effective at treating patients with treatment-resistant schizophrenia, but is severely underutilized despite its efficacy. It does have a significant side effect profile...